BXP Beximco Pharmaceuticals Limited

LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · beximcopharma.com

54.00GBP0.00%Mkt Cap: 308.98M $P/E: 4.503d ago

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and an…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap308.98M USD

Enterprise Value—

Revenue (TTM)—

Gross Profit28.60B USD

Net Income (TTM)8.90B USD

Revenue/Share—

Last Price54.00 GBP

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees6.0K

CountryGB

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)4.50

P/E (Forward)0.07

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.00

EPS (TTM)0.12

EPS (Forward)8.14

52W Range

0.425083% of range65.00

52W High65.00 GBP

52W Low0.4250 GBP

Profitability

Gross Margin45.39%

Oper. Margin0.00%

EBITDA Margin24.31%

Profit Margin14.13%

ROE13.07%

ROA9.48%

Growth

Revenue Growth8.10%

Earnings Growth29.00%

Cash Flow & Leverage

Operating CF9.26B USD

CapEx (TTM)3.89B USD

FCF Margin—

FCF Yield1731.89%

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.09

Current Ratio4.13

Quick Ratio1.40

Book Value/Sh111.35 GBP

Cash/Share—

Dividends

Fwd Div Rate0.03 GBP

Trail. Div Rate0.00 GBP

Div. Yield5.30%

5Y Avg Yield4.92%

Payout Ratio0.00%

Ex-Div DateJul 31, 2026

Pay Date—

Splits

Last Split110:100

Split DateNov 23, 2020

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.446.11M

Float—

Insiders0.00%

Institutions0.21%

Technical

SMA 5056.66 (-4.7%)

SMA 20022.04 (+145.0%)

Beta0.24

S&P 52W Chg14.58%

Avg Vol (30d)30.27K

Avg Vol (10d)27.00K

Technical Indicators

RSI (14)39.6

MACD-0.2849

MACD Signal0.8799

MACD Hist.-1.1648

BB Upper66.11 GBP

BB Middle59.45 GBP

BB Lower52.79 GBP

BB Width22.39%

ATR (14)3.218 GBP

Vol Ratio (20d)1.30x